Lin-Lin Guo1, Ming-Lei Guo2, Jian Yao2, Yun-Qi Weng2, Xue-Zhi Zhang2. 1. Department of Cardiology, The Affiliated Cardiovascular Hospital of Qingdao University, Qingdao, Shandong Province, China. 2. Department of Emergency Medicine, The Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, China.
Abstract
OBJECTIVES: The objective was to investigate the effects of microRNA-421 against myocardial ischemia/reperfusion injury in C57BL/6 mice. METHODS: Male C57BL/6 mice (n = 27) were randomly divided into three groups: normal control (NC) group (sham-treated); I/R model group, which underwent the I30min/R24h model (ischemia for 30 minutes followed by reperfusion for 24 hours); and the miRNA group, which were injected with miR-421. Pathology was assessed by hematoxylin and eosin staining and myocardial infarct size was measured by triphenyltetrazolium chloride staining. The apoptosis rate was measured by TUNEL assay, and relative expression of toll-like receptor-4 (TLR4), Janus kinase 2 (JAK2), and signal transducer and activator of translation 3 (STAT3) was evaluated by immunohistochemistry. Interleukin (IL)-6, tumor necrosis factor (TNF)-α, IL-10, and high mobility group protein B1 (HMGB1) serum concentrations were measured by ELISA. RESULTS: Compared with the NC group, in the model group, the myocardial infarction was large; inflammatory cell infiltration was severe; apoptosis was enhanced; expression of TLR4, JAK2, and STAT3 was increased; and serum concentrations of IL-6, TNF-α, IL-10, and HMGB1 were significantly increased. In the miRNA group, the ischemia/reperfusion injury was significantly improved. CONCLUSIONS: Overexpression of miRNA-421 could reduce ischemia/reperfusion inflammatory response, perhaps via inactivation of TLR4, JAK2, and STAT3.
OBJECTIVES: The objective was to investigate the effects of microRNA-421 against myocardial ischemia/reperfusion injury in C57BL/6 mice. METHODS: Male C57BL/6 mice (n = 27) were randomly divided into three groups: normal control (NC) group (sham-treated); I/R model group, which underwent the I30min/R24h model (ischemia for 30 minutes followed by reperfusion for 24 hours); and the miRNA group, which were injected with miR-421. Pathology was assessed by hematoxylin and eosin staining and myocardial infarct size was measured by triphenyltetrazolium chloride staining. The apoptosis rate was measured by TUNEL assay, and relative expression of toll-like receptor-4 (TLR4), Janus kinase 2 (JAK2), and signal transducer and activator of translation 3 (STAT3) was evaluated by immunohistochemistry. Interleukin (IL)-6, tumor necrosis factor (TNF)-α, IL-10, and high mobility group protein B1 (HMGB1) serum concentrations were measured by ELISA. RESULTS: Compared with the NC group, in the model group, the myocardial infarction was large; inflammatory cell infiltration was severe; apoptosis was enhanced; expression of TLR4, JAK2, and STAT3 was increased; and serum concentrations of IL-6, TNF-α, IL-10, and HMGB1 were significantly increased. In the miRNA group, the ischemia/reperfusion injury was significantly improved. CONCLUSIONS: Overexpression of miRNA-421 could reduce ischemia/reperfusion inflammatory response, perhaps via inactivation of TLR4, JAK2, and STAT3.
Reperfusion therapy for myocardial infarction has advantages and disadvantages. Early and
effective recanalization of coronary blood flow is the most effective method to improve the
prognosis of coronary heart disease, but reperfusion itself can also cause myocardial
injury. The mechanism of ischemia/reperfusion (I/R) injury is complex, and inflammatory
reaction is its characteristic manifestation.[1] Toll-like receptor 4 (TLR4) is an important pathogen recognition signal molecule, and
its mediated inflammatory response plays an important role in the myocardial ischemia
reperfusion injury (MIRI) process.[2] MicroRNAs (miRNAs) are endogenous, regulatory, small non-coding RNAs that regulate
cell differentiation, proliferation, and apoptosis by controlling the translation and
expression of target genes.[3-5] Based on results from previous studies,
miR-421 has an important role in cell apoptosis.[6-8] In those studies,
different target genes of miR-421 were identified. Analysis using bioinformatics software
(http://www.targetscan.org/mamm_31/) indicated that TLR4 was another target
gene of miR-421. We hypothesized that overexpression of miR-421 might improve myocardial
damage induced by I/R via regulation of TLR4 in an in vivo study.
Materials and methods
This animal experiment was approved by the Laboratory Animal Ethics Committee of the
Affiliated Cardiovascular Hospital of Qingdao University, and it conforms to the principles
of animal protection, animal welfare and ethics, and the relevant provisions of the National
Laboratory Animal Welfare ethics.
Reagents
Enhanced chemiluminescence reagent (ECL) highly sensitive luminescent liquid was from
Beyotime Biotech Inc. (Jiangsu, China); polyvinyl difluoride (PVDF) membrane (0.45 µm) was
purchased from GenScript (Nanjing) Co. Ltd. (Nanjing, China); horseradish peroxidase
(HRP)-labeled sheep anti-rabbit, as the secondary antibody, was purchased from GenScript
(Nanjing) Co. Ltd.; and non-fat milk powder was from Oxoid (Basingstoke, UK). Acrylamide
and N,N-methylene-bis-acrylamide, glycine, and
β-mercaptoethanol were from Amresco/VWR International (Radnor, PA, USA). Alkyl sodium
sulfate, persulfate amine, methyl ethylenediamine, trihydroxymethyl aminomethane,
bromophenol blue, nitrocellulose membrane, and the TUNEL kit were from Sigma (St. Louis,
MO, USA). The TLR4, JAK2, and STAT3 antibodies were purchased from Abcam (Cambridge, UK),
and miR-421 was purchased from GenScript (Nanjing) Co. Ltd.
Animal grouping and model preparation
Twenty-seven male C57BL/6 mice (body weight: 20 to 30 g) were purchased from Qingdao
University. The feeding conditions were as follows: room temperature of 21 to 25°C,
12-hour day/night cycle, with free drinking and feeding. The mice were randomly divided
into three groups: mice in the NC group underwent a sham operation (n = 9); mice in the
model group were treated with I30min/R24h model (ischemia for 30
minutes followed by reperfusion for 24 hours) operation (n = 9); and mice in the miRNA
group were injected with 10 mL/kg miR-421 in the caudal vein and underwent the same
ischemia/reperfusion protocol every day (n = 9). The I/R animal model preparation steps
were as follows:[9] narcosis was induced in mice using isoflurane; then, a small incision (around 1.2
cm) was cut in the left thoracic cavity, the tissue was peeled back, and the heart gently
extruded. A slipknot was made around the left anterior descending artery using 6-0 silk.
The heart was then placed back in the chest using 4-0 silk and the skin sutured, leaving
the 6-0 slipknot outside. After 30 minutes of ischemia, the slipknot was released to allow
recovery of coronary artery perfusion. Mice in the miRNA group were injected with 0.2 mL
of miR-421 in the caudal vein 7 days before model preparation. Mice in the other two
groups were injected with 0.2 mL of 0.9% normal saline. All mice survived following the
24-hour reperfusion. The pathological morphology and cardiac function of mice were
detected by hematoxylin and eosin (H&E) and triphenyltetrazolium chloride (TTC)
staining, respectively, to verify the model.
H&E staining
After 24 hours of reperfusion, the myocardial tissue of mice was collected and
paraffin-embedded sections were prepared and stained with H&E. Pathological changes
were observed using an optical microscope under 200× magnification.
Evans blue and TTC staining
After reperfusion for 24 hours, mice were injected in the aorta with 1% Evans blue and
then the heart was removed and cut into slices 1 mm thick. Cardiac slices were incubated
in TTC solution at 37°C for 15 minutes. The infarct area (IA), area at risk (AAR), and
left ventricle (LV) were measured by Photoshop CS5 software (Adobe Inc., San Jose, CA,
USA).
TUNEL assay
The cardiac tissues were placed in 4% paraformaldehyde to fix, and paraffin-embedded
sections were prepared according to the instructions of the terminal deoxynucleotidyl
transferase mediated dUTP biotin nick-end labeling (TUNEL) kit. Cardiac tissue slices were
observed under the microscope; the nucleus and cytoplasm were dense and fluorescence was
positive. The cardiac tissues were stained with PBS as negative control in this
experiment. At high magnification, five visual fields were randomly selected and the
apoptotic cells in those fields were counted.
Immunohistochemistry (IHC) assay
Protein expression of TLR4, JAK2, and STAT3 in cardiac tissue slices (4 µm) was measured
by horseradish peroxidase method as described in the literature.[10] Briefly, paraffin sections of tissue were made, followed by dewaxing, hydration,
antigen repair, and incubation with 3% H2O2 at room temperature for
10 minutes to eliminate endogenous peroxidase activity. Then, sections were incubated at
37°C for 15 minutes with the addition of sealing solution, followed by discarding of the
sealing solution without washing. The primary antibody (1:100) was added and incubated at
4°C overnight. The section was removed the next day, the corresponding biotin-labeled
second antibody was added, and the section incubated at 37°C for 15 minutes, followed by
the dripping of horseradish peroxidase-labeled working solution of
Streptomyces ovalbumin and incubation at 37°C for 10 to 15 minutes.
After development with DAB for 1 to 2 minutes, the reaction was stopped by rinsing with
tap water, followed by washing with tap water, and restaining with hematoxylin,
dehydration, and sealing with neutral gum. All pathological sections were scored by two
experienced pathologists without clinical pathological data. If the results differed, they
were assessed again until consensus was reached. The intensity of immunohistochemical
staining was divided into five grades (from 0 to 4), and the percentage of specific
pigmented cells (0% to 100%) was assessed in five fields of view: 0 (no expression,
positive cell number <5%), 1 (low expression, positive cell number between 5% and 25%),
2 (middle expression, positive cell number between 25% and 50%), 3 (high expression,
positive cell number between 50% and 75%), and 4 (high expression, positive cell number is
≥75%).
ELISA assay
After reperfusion for 24 hours, blood of the carotid artery was collected before cardiac
tissues were harvested. Blood was left for 2 hours and then centrifuged at
2,500 × g for 10 min. The serum was used to measure concentrations of
interleukin (IL)-6, tumor necrosis factor (TNF)-α, IL-10, and high mobility group protein
B1 (HMGB1) by ELISA kit (Sigma, St. Louis, MO, USA).
Statistical analysis
The data of this study were analyzed using IBM SPSS Statistics for Windows, version 19.0
(IBM Corp., Armonk, NY, USA), and data are expressed as mean ± standard deviation (SD).
Analysis of variance was used to analyze differences between groups. The
t-test was used to analyze the variance between groups, and one-way
ANOVA was used. A p-value < 0.05 indicated a significant
difference.
Results
Myocardial pathology
H&E staining of myocardial tissues from mice in the NC group showed that the
myocardial stripes were clear, the arrangement of myocardial fibers was regular, the
nuclei were normal, and no hyperemia, hemorrhage, or inflammatory reaction was found in
the interstitium. In mice of the I/R model group, the myocardial cross striation
disappeared and the myocardial cells were disordered and accompanied by degeneration and
necrosis. In the miRNA group, the morphological structure of myocardial tissue was
intermediate between that of the I/R model group and the NC group, and the degree of
degeneration and necrosis of myocardial cells were alleviated (Figure 1).
Figure 1.
Pathology of difference groups by hematoxylin and eosin staining (200×
magnification).
NC, normal control mice (treated with sham operation); Model: ischemia/reperfusion
(I/R) model group mice; miRNA, mice injected with miR-421 and then subjected to the
I/R procedure.
Pathology of difference groups by hematoxylin and eosin staining (200×
magnification).NC, normal control mice (treated with sham operation); Model: ischemia/reperfusion
(I/R) model group mice; miRNA, mice injected with miR-421 and then subjected to the
I/R procedure.
Myocardial infarct area
We observed no significant differences among the three groups (NC, I/R model, and miRNA)
in AAR. However, the IA of mice in the I/R model group was significantly increased
compared with that of the NC group (p < 0.001), and the IA of the
miRNA group was significantly improved (p < 0.05). compared with that
of the I/R model group. Data are shown in Figure 2.
Figure 2.
The effect of miR-421 on myocardial infarct sizes of ischemia/reperfusion (I/R) mice.
(a) NC, normal control mice (treated with sham operation). (b) Model,
ischemia/reperfusion (I/R) model group mice. (c) miRNA, mice injected with miR-421
based on model; AAR, area at risk; LV, left ventricle; IA, infarct area.
***p < 0.05, compared with NC group;
#p < 0.05, compared with Model group.
The effect of miR-421 on myocardial infarct sizes of ischemia/reperfusion (I/R) mice.
(a) NC, normal control mice (treated with sham operation). (b) Model,
ischemia/reperfusion (I/R) model group mice. (c) miRNA, mice injected with miR-421
based on model; AAR, area at risk; LV, left ventricle; IA, infarct area.
***p < 0.05, compared with NC group;
#p < 0.05, compared with Model group.
Cell apoptosis rate
Compared with the NC group, the number of cells positive for apoptosis in the I/R model
group was significantly increased (p < 0.001); however, the apoptosis
rate in the miRNA group was significantly decreased compared with that of the I/R model
group (p < 0.05). The relative data are shown in Figure 3.
Figure 3.
Apoptosis of cardiomyocytes in different groups by terminal deoxynucleotidyl
transferase mediated dUTP biotin nick-end labeling (TUNEL) assay (200× magnification).
NC, normal control mice (treated with sham operation); Model, ischemia/reperfusion
(I/R) model group mice; miRNA, mice injected with miR-421 based on model.
***p < 0.05, compared with NC group;
#p < 0.05, compared with Model group.
Apoptosis of cardiomyocytes in different groups by terminal deoxynucleotidyl
transferase mediated dUTP biotin nick-end labeling (TUNEL) assay (200× magnification).
NC, normal control mice (treated with sham operation); Model, ischemia/reperfusion
(I/R) model group mice; miRNA, mice injected with miR-421 based on model.
***p < 0.05, compared with NC group;
#p < 0.05, compared with Model group.
Relative protein expression
Compared with expression in the NC group, the expression of TLR4, JAK2, and STAT3 in the
I/R model group was significantly upregulated, as shown by immunohistochemistry
(p < 0.001). However, expression of these proteins in the miRNA
group (with miR-421 overexpression) was significantly downregulated compared with that in
the I/R model group (p < 0.05, respectively). The data are shown in
Figures 4–6.
Figure 4.
Expression of TLR4 protein in different groups by immunohistochemistry (200×
magnification). NC, normal control mice (treated with sham operation); Model,
ischemia/reperfusion (I/R) model group mice; miRNA, mice injected with miR-421 based
on model; TLR4, toll-like receptor 4. ***p < 0.05, compared with
NC group; #p < 0.05, compared with Model group.
Figure 5.
Expression of JAK2 protein in different groups by immunohistochemistry (200×
magnification). NC, normal control mice (treated with sham operation); Model,
ischemia/reperfusion (I/R) model group mice; miRNA, mice injected with miR-421 based
on model; JAK2, Janus kinase 2. ***p < 0.05, compared with NC
group; #p < 0.05, compared with Model group.
Figure 6.
Expression of STAT3 protein in different groups by immunohistochemistry (200×
magnification). NC, normal control mice (treated with sham operation); Model,
ischemia/reperfusion (I/R) model group mice; miRNA, mice injected with miR-421 based
on model; STAT3, signal transducer and activator of transcription 3.
***p < 0.05, compared with NC group;
#p < 0.05, compared with Model group.
Expression of TLR4 protein in different groups by immunohistochemistry (200×
magnification). NC, normal control mice (treated with sham operation); Model,
ischemia/reperfusion (I/R) model group mice; miRNA, mice injected with miR-421 based
on model; TLR4, toll-like receptor 4. ***p < 0.05, compared with
NC group; #p < 0.05, compared with Model group.Expression of JAK2 protein in different groups by immunohistochemistry (200×
magnification). NC, normal control mice (treated with sham operation); Model,
ischemia/reperfusion (I/R) model group mice; miRNA, mice injected with miR-421 based
on model; JAK2, Janus kinase 2. ***p < 0.05, compared with NC
group; #p < 0.05, compared with Model group.Expression of STAT3 protein in different groups by immunohistochemistry (200×
magnification). NC, normal control mice (treated with sham operation); Model,
ischemia/reperfusion (I/R) model group mice; miRNA, mice injected with miR-421 based
on model; STAT3, signal transducer and activator of transcription 3.
***p < 0.05, compared with NC group;
#p < 0.05, compared with Model group.
Concentrations of IL-6, TNF-α, IL-10, and HMGB1
Compared with those in the NC group, concentrations of IL-6, TNF-α, IL-10, and HMGB1 were
significantly increased in the I/R model group (all p < 0.05);
however, in the miR-421 group, concentrations of IL-6 and TNF-α were significantly lower
and those of IL-10 and HMGB1 of were significantly higher than those of the I/R model
group (p < 0.05, respectively). The relative data are shown in Figure 7.
Figure 7.
Effects of miR-421 on the serum level of inflammatory cytokines of
ischemia/reperfusion (I/R) model mice. NC, normal control mice (treated with sham
operation); Model, I/R model group mice; miRNA, mice injected with miR-421 based on
model; IL, interleukin, TNF-α, tumor necrosis factor-α; HMGB1, high mobility group
protein B1.
***p < 0.05, compared with NC group;
#p < 0.05, compared with Model group.
Effects of miR-421 on the serum level of inflammatory cytokines of
ischemia/reperfusion (I/R) model mice. NC, normal control mice (treated with sham
operation); Model, I/R model group mice; miRNA, mice injected with miR-421 based on
model; IL, interleukin, TNF-α, tumor necrosis factor-α; HMGB1, high mobility group
protein B1.***p < 0.05, compared with NC group;
#p < 0.05, compared with Model group.
Discussion
TLR4 is an important pathogen pattern recognition signal molecule, and its mediated
inflammatory response plays an important role in the MIRI process.[11] Defects in TLR4 signal transduction can reduce infarct size during ischemia
reperfusion and reduce inflammation associated with myocardial injury, including neutrophil
aggregation, oxidative stress, and activation of complement deposition.[12] In patients with coronary heart disease after reperfusion therapy, TLR4
overexpression in peripheral blood monocytes and the induced release of serum inflammatory
factors aggravate myocardial injury.[13] miRNA is a highly conserved, non-coding, small single-stranded RNA in eukaryotes that
can regulate gene expression and participate in cell differentiation, proliferation, and
apoptosis. The expression of miRNA is specific. The results suggest that miRNA expressed in
the heart is involved in cardiovascular diseases.[14-16] Based on bioinformatics software, we found that miR-421 might target
TLR4. In the current study, we investigated the effects and mechanisms of miR-421 in
improving myocardial damage induced by I/R.We investigated the molecular mechanism of miR-421 inhibiting and ameliorating the I/R
inflammatory response and apoptosis in I/R model mice by injecting miR-421 into the tail
vein. Our results showed that myocardial injury, myocarditis infiltration, and myocardial
infarction were observed in I/R model mice; however, miR-421 treatment significantly
decreased the infiltration of myocarditis and the degree of apoptosis of myocardial cells.
Overexpression of miR-421 could work to ameliorate I/R injury by regulation of the
TLR4/JAK2/STAT3 pathways.The JAK2/STAT3 signaling pathway is involved in cell proliferation, differentiation,
apoptosis, inflammation and immune regulation, and many other important biological
processes. Studies have shown that inhibition of JAK2/STAT3 activation protects against
fructose-induced hepatitis, and the JAK2 signaling pathway associated with TLR4 plays an
important role in phagocytosis of macrophages.[17],[18] The protective effect of berberine on myocardial I/R damage is related to JAK2/STAT3
signaling pathway and endoplasmic reticulum stress.[19] Cardioprotective preconditioning with remifentanil also activates the JAK2/STAT3 pathway.[20] In this study, by detecting the expression level of JAK2/STAT3, we found that
expression of JAK2/STAT3 in the miRNA group was reduced compared with that in the I/R model
group. Thus, the protective effect of miR-421 on I/R mice is related to inactivation of the
JAK2/STAT3 signaling pathway.IL-6 and TNF-α are proinflammatory factors, and IL-10 is an anti-inflammatory factor. HMGB1
is a non-histone nuclear protein widely distributed in eukaryotic cells. It maintains
nucleosome structure and regulates gene transcription in cells. After cell necrosis or when
immune cells are stimulated by pathogens, HMGB1 is secreted to the extracellular region and
actively migrates to the target organ or tissue site. As an important inflammatory cytokine,
it participates in the inflammatory response of MIRI.[21-23] Serum HMGB1 concentration is closely related to the severity of
myocardial ischemia and the effect of reperfusion therapy in patients with coronary heart disease.[24] Inhibition of HMGB1 activity has protective effects on animal models of infectious
diseases induced by infectious factors and noninfectious injuries.[25] Our results showed that the expression of proinflammatory cytokines IL-6 and TNF-α
increased in I/R model mice, while the serum anti-inflammatory factors IL-10 and HMGB1
showed a compensatory decrease. Thus, miR-421 can not only inhibit the expression of
proinflammatory cytokines IL-6 and TNF-α, but also upregulate the expression of
anti-inflammatory factors IL-10 and HMGB1, suggesting that miR-421 may play a
cardioprotective role by inhibiting inflammation via regulation of TLR4 expression.In conclusion, miR-421 overexpression had protective effects on myocardial
ischemia/reperfusion injury in C57BL/6 mice, including reducing infarct size, improving
cardiac function, inhibiting inflammatory response, and regulating the expression of
inflammatory cytokines in serum. The effects of miR-421 might be related to the
TLR4/JAK2/STAT3 pathway.
Authors: H Wang; O Bloom; M Zhang; J M Vishnubhakat; M Ombrellino; J Che; A Frazier; H Yang; S Ivanova; L Borovikova; K R Manogue; E Faist; E Abraham; J Andersson; U Andersson; P E Molina; N N Abumrad; A Sama; K J Tracey Journal: Science Date: 1999-07-09 Impact factor: 47.728
Authors: Shigang Qiao; Xiaowen Mao; Yan Wang; Shaoqing Lei; Yanan Liu; Tingting Wang; Gordon T Wong; Chi-Wai Cheung; Zhengyuan Xia; Michael G Irwin Journal: Crit Care Med Date: 2016-03 Impact factor: 7.598
Authors: Ammad Ahmad Farooqi; Muhammad Zahid Qureshi; Ender Coskunpinar; Syed Kamran-Ul-Hassan Naqvi; Ilhan Yaylim; Muhammad Ismail Journal: Asian Pac J Cancer Prev Date: 2014
Authors: Martin Andrassy; Hans C Volz; John C Igwe; Benjamin Funke; Sebastian N Eichberger; Ziya Kaya; Sebastian Buss; Frank Autschbach; Sven T Pleger; Ivan K Lukic; Florian Bea; Stefan E Hardt; Per M Humpert; Marco E Bianchi; Heimo Mairbäurl; Peter P Nawroth; Andrew Remppis; Hugo A Katus; Angelika Bierhaus Journal: Circulation Date: 2008-06-24 Impact factor: 29.690
Authors: Erhe Gao; Yong Hong Lei; Xiying Shang; Z Maggie Huang; Lin Zuo; Matthieu Boucher; Qian Fan; J Kurt Chuprun; Xin L Ma; Walter J Koch Journal: Circ Res Date: 2010-10-21 Impact factor: 17.367